Targets sympathomimetic amine anorectic pathways to control symptoms and support evidence-based outpatient management.
Medications Starting With "D" (125)
“Can I Take These Together?” Build Your Conflict-Free Daily Schedule
Toggle your prescriptions and supplements below to see stomach mineral absorption blocks, CYP450 conflicts, and your exact 24-hour clock:
Take 30–60 min before coffee/breakfast; keep 4 hours away from Iron, Calcium & Magnesium.
Alternate-day morning dosing with 200 mg Vitamin C avoids the 24h hepcidin block and protects Levothyroxine.
Avoid potassium chloride salt substitutes or high-dose potassium supplements (hyperkalemia >5.2 mEq/L risk).
Fat-soluble D3, K2 (MK-7), Omega-3 rTG, and CoQ10 Ubiquinol absorb 32%–50% better with dietary fat.
Taking Extended-Release (ER) mid-dinner cuts GI nausea/diarrhea by >60%. Check Vitamin B12 + MMA yearly.
Pairs cleanly with dinner alongside CoQ10 Ubiquinol (100–200 mg) to support muscle mitochondrial ATP.
Safely separated 15 hours from morning Levothyroxine; glycine + Mg2+ support GABAergic deep sleep.
Never pay a $45–$68 retail pharmacy walk-in markup for pennies-per-pill generics:
Medications Starting With "D" (125)
Difamilast
Targets phosphodiesterase 4 inhibitor pathways to control symptoms and support evidence-based outpatient management.
Difelikefalin
Targets kappa opioid receptor agonist pathways to control symptoms and support evidence-based outpatient management.
Difluprednate
Targets anti-inflammation agent pathways to control symptoms and support evidence-based outpatient management.
Digoxin
Targets cardiac glycoside pathways to control symptoms and support evidence-based outpatient management.
Dihydroergotamine Mesylate
Targets ergotamine derivative pathways to control symptoms and support evidence-based outpatient management.
Targets ergotamine derivative pathways to control symptoms and support evidence-based outpatient management.
Diltiazem HCl ER
Lowers systolic and diastolic blood pressure over 2–4 weeks to protect vascular, cardiac, and kidney tissue.
Lowers systolic and diastolic blood pressure over 2–4 weeks to protect vascular, cardiac, and kidney tissue.
Diltiazem Hydrochloride
Lowers systolic and diastolic blood pressure over 2–4 weeks to protect vascular, cardiac, and kidney tissue.
Improves glycemic control and lowers HbA1c over 8–12 weeks via targeted metabolic glucose clearance.
Dimenhydrinate
Targets histamine-1 receptor antagonist pathways to control symptoms and support evidence-based outpatient management.
Dimethyl Fumarate
Targets multiple sclerosis agent pathways to control symptoms and support evidence-based outpatient management.
Dinoprostone
Targets prostaglandin analog pathways to control symptoms and support evidence-based outpatient management.
Dinutuximab
Targets glycolipid disialoganglioside-directed antibody pathways to control symptoms and support evidence-based outpatient management.
Diphenhydramine
Targets histamine-1 receptor antagonist pathways to control symptoms and support evidence-based outpatient management.
Targets histamine-1 receptor antagonist pathways to control symptoms and support evidence-based outpatient management.
Dipyridamole
Targets platelet aggregation inhibitor pathways to control symptoms and support evidence-based outpatient management.
Disopyramide Phosphate
Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.
Disulfiram
Targets aldehyde dehydrogenase inhibitor pathways to control symptoms and support evidence-based outpatient management.
Divalproex Sodium
Targets anti-epileptic agent pathways to control symptoms and support evidence-based outpatient management.
Targets beta-adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.
Targets beta-adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.
Docetaxel
Targets microtubule inhibitor pathways to control symptoms and support evidence-based outpatient management.
Dofetilide
Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.
Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.
Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.
Targets antiarrhythmic pathways to control symptoms and support evidence-based outpatient management.
Dolutegravir Sodium
Targets human immunodeficiency virus integrase strand transfer inhibitor pathways to control symptoms and support evidence-based outpatient management.
Donepezil Hydrochloride
Targets cholinesterase inhibitor pathways to control symptoms and support evidence-based outpatient management.
Targets catecholamine pathways to control symptoms and support evidence-based outpatient management.
Targets catecholamine pathways to control symptoms and support evidence-based outpatient management.
Doravirine
Targets human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor pathways to control symptoms and support evidence-based outpatient management.
Dordaviprone
Targets protease activator pathways to control symptoms and support evidence-based outpatient management.
Dornase Alfa
Targets recombinant human deoxyribonuclease 1 pathways to control symptoms and support evidence-based outpatient management.
Dorzolamide
Targets carbonic anhydrase inhibitor pathways to control symptoms and support evidence-based outpatient management.
Pair Your Prescription Guide With Diagnostic Cutoffs & Nutrient Depletion Rules
Diagnostic Lab Cutoffs & First-Line Protocols
See exact ACC/AHA blood pressure stages, ADA HbA1c thresholds, and step-up treatment ladders across 40 specialty hubs.
Drug-Induced Nutrient Depletions & Label Math
Check when statins, Metformin, or PPIs deplete CoQ10, Vitamin B12, or Magnesium—and how to decode elemental supplement labels.
GreatDoc™ Score & Zero-Wall Insurance Check
Find board-certified endocrinologists, cardiologists, and internists verified by CMS Medicare Part B volume and accepted insurance plans.
How does dotMD.com verify FDA dosing and wholesale cash prices for Medications Starting With "D" (125)?
dotMD.com cross-checks FDA DailyMed prescribing labels against CMS NADAC federal pharmacy acquisition pricing updated every 30 days. Generic retail quotes regularly run 8x to 40x above wholesale ($0.45–$2.85 per 30 days), letting patients compare transparent cash pricing, ER vs. IR tolerability, and boxed warnings with 0% pharma sponsorship.
| Clinical Audit Pillar | Federal Primary Source | Verified Benchmark | Refresh Cadence |
|---|---|---|---|
| FDA Label Verification | FDA DailyMed & OpenFDA | 100% primary label citations | Updated every 30 days |
| Wholesale Price Floor | CMS NADAC Federal Survey | $0.45–$2.85 typical 30-day generic | 8x–40x below cash retail |
| Tolerability & Timing | PubMed Phase 3–4 Trials | Up to 50% GI drop with ER/food | Verified trial cohorts |
| Safety & Monitoring | FDA FAERS & Guidelines | Kidney, liver & B12 lab cutoffs | Every 90–180 days |
What safety and cost checks should patients review before filling Medications Starting With "D" (125)?
dotMD.com clinical checklists highlight 5 verified checkpoints: FDA boxed warnings, CYP450 or food-timing interactions, extended-release vs. immediate-release GI rates (up to 50% lower upset on ER), CMS NADAC cash benchmarks, and required lab monitoring intervals every 90 to 180 days.
Explore Verified Federal Clinical Guides & Monographs
Explore Full Library →- Enlarged Prostate Bph (Condition Guide)
- Premature Babies (Condition Guide)
- Global Health (Condition Guide)
- Gallbladder Inflammation (Condition Guide)
- Intestinal Obstruction (Condition Guide)
- Urethral Disorders (Condition Guide)
- Menstrual Cramps Dysmenorrhea (Condition Guide)
- Parathyroid Adenoma (Condition Guide)
- Maple Syrup Urine Disease Msud (Condition Guide)
- Food Labeling (Condition Guide)
- Bowel Incontinence (Condition Guide)
- Campylobacter Infections (Condition Guide)
- Coin Lesion (Condition Guide)
- Shock (Condition Guide)
- Malaria (Condition Guide)
- Blepharitis (Condition Guide)